Gene expression profiling of the synergy of 5-aza-2^′-deoxycytidine and paclitaxel against renal cell carcinoma

<p>Abstract</p> <p>Background</p> <p>Renal cell carcinoma (RCC) is one of the most common kidney cancers and is highly resistant to chemotherapy. We previously demonstrated that 5-aza-2^′-deoxycytidine (DAC) could significantly increase the susceptibility of renal cell carcinoma (RCC) cell...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Han Tiandong, Shang Donghao, Xu Xiuhong, Tian Ye
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2012-09-01
coleção:	World Journal of Surgical Oncology
Assuntos:	Synergy 5-aza-2<sup>′</sup>-deoxycytidine Paclitaxel Renal cell carcinoma PI3K/Akt
Acesso em linha:	http://www.wjso.com/content/10/1/183
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!